Port Erin Biopharma Investments Ltd (LON:PEBI)‘s stock had its “corporate” rating reaffirmed by stock analysts at Northland Securities in a research note issued on Thursday.

Port Erin Biopharma Investments (LON PEBI) remained flat at GBX 5.00 during mid-day trading on Thursday. 116,992 shares of the company’s stock were exchanged. The firm’s market capitalization is GBX 1.16 million. Port Erin Biopharma Investments has a 12-month low of GBX 4.85 and a 12-month high of GBX 9.25. The stock has a 50-day moving average price of GBX 5.25 and a 200 day moving average price of GBX 5.68.

COPYRIGHT VIOLATION WARNING: This news story was posted by American Banking News and is the sole property of of American Banking News. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright laws. The correct version of this news story can be read at https://www.americanbankingnews.com/2017/10/22/port-erin-biopharma-investments-ltd-pebi-rating-reiterated-by-northland-securities.html.

About Port Erin Biopharma Investments

Port Erin Biopharma Investments Limited is an Isle of Man-based company, which was formed for the purpose of investing in the biotechnology and biopharmaceutical sector. The Company’s focuses on investing in companies that have the potential to generate revenues through the development of biopharmaceutical drugs.

Receive News & Ratings for Port Erin Biopharma Investments Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Port Erin Biopharma Investments Ltd and related companies with MarketBeat.com's FREE daily email newsletter.